Journal
PSYCHIATRY INVESTIGATION
Volume 5, Issue 3, Pages 142-147Publisher
KOREAN NEUROPSYCHIATRIC ASSOC
DOI: 10.4306/pi.2008.5.3.142
Keywords
Triple reuptake inhibitor; Serotonin; Norephinephrine; Dopamine
Categories
Ask authors/readers for more resources
On the horizon there is a new class of psychoactive medications which work by inhibiting the neuronal reuptake of serotonin, norepinephrine, and dopamine. There are multiple potential indications for these drugs. Research suggests that they may have a role in treating depressive disorders, and it is plausible they may have potential efficacy in obesity, addiction, and pain syndromes. The current review describes some of the molecules in development presently and explores the research relevant to possible clinical uses for this class of medications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available